12-2679597-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2
The ENST00000399655.6(CACNA1C):c.5245G>A(p.Val1749Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000171 in 1,461,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1749A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000399655.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5479G>A | p.Val1827Met | missense_variant | 44/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5245G>A | p.Val1749Met | missense_variant | 42/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5212G>A | p.Val1738Met | missense_variant | 41/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5410G>A | p.Val1804Met | missense_variant | 43/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5389G>A | p.Val1797Met | missense_variant | 44/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5368G>A | p.Val1790Met | missense_variant | 42/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5245G>A | p.Val1749Met | missense_variant | 42/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5245G>A | p.Val1749Met | missense_variant | 42/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5335G>A | p.Val1779Met | missense_variant | 42/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5335G>A | p.Val1779Met | missense_variant | 42/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5335G>A | p.Val1779Met | missense_variant | 42/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5335G>A | p.Val1779Met | missense_variant | 42/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5329G>A | p.Val1777Met | missense_variant | 43/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5320G>A | p.Val1774Met | missense_variant | 43/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5305G>A | p.Val1769Met | missense_variant | 43/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5302G>A | p.Val1768Met | missense_variant | 42/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5302G>A | p.Val1768Met | missense_variant | 42/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5302G>A | p.Val1768Met | missense_variant | 42/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5296G>A | p.Val1766Met | missense_variant | 42/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5287G>A | p.Val1763Met | missense_variant | 42/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5269G>A | p.Val1757Met | missense_variant | 41/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5269G>A | p.Val1757Met | missense_variant | 41/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5263G>A | p.Val1755Met | missense_variant | 41/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5245G>A | p.Val1749Met | missense_variant | 42/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5236G>A | p.Val1746Met | missense_variant | 42/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5212G>A | p.Val1738Met | missense_variant | 41/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461452Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727002
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
CACNA1C-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 31, 2023 | The CACNA1C c.5245G>A variant is predicted to result in the amino acid substitution p.Val1749Met. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 14, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CACNA1C-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with methionine at codon 1749 of the CACNA1C protein (p.Val1749Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at